Corvus Pharmaceuticals, Inc.
- Last sale
- Nov 12, 2026 · -7.58%
- Market cap
- $895.41M
- 84.35M shares
- Filings
- 585
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−47.6% FY25 yoy
- $895.41M
- —
- —
- 4.3×
- -3.68%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $33,719,000 | reported | |
| FY 2024 | 2024-12-31 | $19,385,000 | reported | |
| FY 2023 | 2023-12-31 | $16,526,000 | reported | |
| FY 2021 | 2022-12-31 | $24,468,000 | reported | |
| FY 2020 | 2021-12-31 | $29,115,000 | reported | |
| FY 2019 | 2020-12-31 | $31,830,000 | reported | |
| FY 2018 | 2018-12-31 | $38,586,000 | reported | |
| FY 2017 | 2017-12-31 | $46,305,000 | reported | |
| FY 2016 | 2016-12-31 | $29,356,000 | reported | |
| FY 2015 | 2015-12-31 | $11,352,000 | reported | |
| FY 2014 | 2014-12-31 | $38,000 | reported |
Pharmaceutical preparations
Corvus Pharmaceuticals, Inc. is the 149th largest of the 554 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
CYRXCryoport, Inc.$176.2M12.4%44.4%$968.4MPHARPharming Group N.V.$376.1M26.6%0.8%$922.0M
CRVSCorvus Pharmaceuticals, Inc. (this company)———$895.4M
AKTSAktis Oncology, Inc.———$879.8MORICOric Pharmaceuticals, Inc.———$879.0MRIGLRigel Pharmaceuticals Inc$294.3M64.1%124.7%$855.8MLTGOLatigo Biotherapeutics, Inc.———$855.3MLXRXLexicon Pharmaceuticals, Inc.$49.8M729.9%101.1%$812.6MIRWDIronwood Pharmaceuticals Inc$296.2M15.7%8.1%$801.3MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Corvus Pharmaceuticals, Inc. · CIK 1626971 · Engraved from SEC EDGAR